Cognition Therapeutics In...

NASDAQ: CGTX · Real-Time Price · USD
1.54
-0.12 (-7.23%)
At close: Aug 15, 2025, 3:59 PM
1.57
1.62%
After-hours: Aug 15, 2025, 07:56 PM EDT

Cognition Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
250K 250K 250K 372K 372K 372K 372K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
247K 253K 266K 261K 256K 250K 252K 246K 241K 239K 235K 198K 161K 126K 93K 70K 47K 23K
Gross Profit
-247K -253K -266K 111K 116K 122K 120K -246K -241K -239K -235K -198K -161K -126K -93K -70K -47K -23K
Operating Income
-52.94M -53.64M -53.97M -58.43M -58.71M -55.85M -50.72M -44.84M -42.72M -43.11M -43.55M -46.06M -38.66M -32.43M -28.6M -20.91M -20.15M -18.1M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
-32.99M -33.3M -33.97M -34.27M -31.08M -28.77M -25.79M -22.83M -22.7M -23.86M -21.4M -23.55M -20.04M -15.65M -11.72M -6.25M -4.93M -5.11M
Net Income
-32.99M -33.3M -33.97M -34.27M -31.08M -28.77M -23M -3.88M 2.24M 1.21M 757K -17.55M -20.04M -15.78M -11.72M -6.25M -4.93M -5.11M
Selling & General & Admin
11.13M 11.73M 12.23M 13.19M 13.19M 13.41M 13.46M 12.8M 14.08M 13.88M 13.23M 16.6M 13.79M 11.77M 10.03M 4.62M 4.14M 4.23M
Research & Development
41.81M 41.91M 41.68M 45.12M 45.4M 42.32M 37.2M 32.04M 28.64M 29.24M 30.32M 29.46M 24.86M 20.66M 18.57M 16.29M 16.01M 13.87M
Other Expenses
-71K -71K -71K n/a n/a 172K -3.25M -7.24M -13.18M -13.4M -15.87M -12.5M -7.47M -8.37M -2.32M -1.59M -572K 485K
Operating Expenses
52.87M 53.57M 53.84M 58.31M 58.59M 48.8M 40.31M 30.5M 22.44M 23.37M 21.33M 22.75M 18.26M 13.77M 11.15M 5.83M 4.91M 4.83M
Interest Expense
6K 10K 25K 29K 28K 27K 27K 28K 28K 29K 28K 18K 16K 366K 894K 1.42M 1.93M 2.01M
Selling & Marketing Expenses
n/a n/a -58K -124K -124K -124K -66K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
52.94M 53.64M 53.97M 58.43M 58.71M 48.93M 40.37M 30.5M 22.44M 23.37M 21.33M 22.75M 18.26M 13.77M 11.15M 5.83M 4.91M 4.83M
Income Tax Expense
n/a n/a n/a n/a n/a n/a -2.79M -18.95M -24.95M -25.07M -22.15M -6M n/a 125K n/a n/a n/a n/a
Shares Outstanding (Basic)
63.69M 61.83M 46.43M 40.42M 40.06M 33.74M 30.78M 30.37M 29.61M 29.09M 28.99M 23.02M 22.6M 22.43M 20.95M 20.95M 20.95M 21.37M
Shares Outstanding (Diluted)
63.69M 61.83M 46.43M 40.42M 40.06M 33.74M 30.78M 30.37M 29.61M 29.09M 28.99M 23.02M 22.6M 22.43M 20.95M 20.95M 20.95M 21.37M
EPS (Basic)
-0.67 -0.74 -0.87 -0.96 -0.93 -0.91 -0.76 -0.12 0.07 -0.02 -0.07 -0.8 -0.92 -0.74 -0.56 -0.3 -0.23 -0.24
EPS (Diluted)
-0.67 -0.74 -0.87 -0.96 -0.93 -0.91 -0.76 -0.12 0.07 -0.02 -0.07 -0.8 -0.92 -0.74 -0.56 -0.3 -0.23 -0.24
EBITDA
-45.38M -38.37M -33.68M -33.98M -30.8M -28.49M -25.51M -22.55M -22.44M -23.59M -21.13M -23.34M -19.86M -15.16M -10.73M -7.51M -5.68M -5.78M
EBIT
-32.98M -33.28M -33.95M -34.24M -31.05M -28.74M -25.76M -22.8M -22.68M -23.83M -21.37M -23.54M -20.02M -15.29M -10.82M -4.82M -3M -3.1M
Depreciation & Amortization
186K 253K 266K 261K 256K 250K 252K 246K 241K 239K 235K 198K 161K 126K 93K 94K 95K 96K